Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(11%)
Results Posted
25%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
4
44%
Ph phase_4
2
22%
Ph phase_3
1
11%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(3)

Detailed Status

Completed4
unknown3
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (14.3%)
Phase 42 (28.6%)
N/A4 (57.1%)

Trials by Status

recruiting111%
terminated111%
unknown333%
completed444%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DEVICE
Total Trials
9